Advanced Drainage Systems (WMS) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
5 Feb, 2026Executive summary
Net sales for Q3 FY26 rose 0.4% year-over-year to $693.4 million, with net income up 14.3% to $94.0 million and diluted EPS up 14.4% to $1.19.
Adjusted EBITDA for Q3 grew 9.3% to $209.2 million, with margin improving by 250 basis points to 30.2% on favorable mix and pricing.
Year-to-date net sales increased 3.7% to $2.4 billion, net income up 5.0% to $394.6 million, and diluted EPS up 5.2% to $5.02.
Allied Products and Infiltrator segments drove growth, supported by new products, expanded distribution, and acquisitions.
Completed the NDS acquisition, expanding the product portfolio and distribution channels.
Financial highlights
Q3 gross profit increased 7.3% to $259.2 million, with gross margin at 37.4%; year-to-date gross profit rose 7.1% to $929.7 million, with margin at 39.2%.
Year-to-date Adjusted EBITDA was $774.9 million, up 8.8%, with margin at 32.6%.
Free cash flow for the nine months was $582.4 million, and net cash from operations was $779.1 million.
Ended the quarter with $1.0 billion in cash and total liquidity of $1.6 billion.
Net leverage at 0.5x as of December 31, 2025, and 1.5x post-NDS acquisition.
Outlook and guidance
FY26 net sales guidance raised to $2.99–$3.04 billion; Adjusted EBITDA guidance increased to $930–$960 million, with margin expected at 31.1–31.6%.
Guidance includes $40 million in revenue and a 20% EBITDA margin from NDS for the remainder of the fiscal year.
Capital expenditures projected at approximately $250 million for FY26.
Fourth quarter expected to be variable due to weather impacts and macroeconomic uncertainty.
Sufficient liquidity is expected to meet obligations for at least the next twelve months.
Latest events from Advanced Drainage Systems
- Q1 sales up 4.8% to $815M; 2025 outlook reaffirmed despite margin pressure.WMS
Q1 20252 Feb 2026 - Flat Q2 sales, resilient margins, and Orenco acquisition support long-term growth.WMS
Q2 202515 Jan 2026 - Net sales up 4.3%–4% in Q3 FY25, but net income and margins declined amid higher costs.WMS
Q3 20258 Jan 2026 - Record profitability, strong ESG progress, and performance-based executive pay define FY2024.WMS
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, auditor, and executive pay amid strong ESG focus.WMS
Proxy Filing1 Dec 2025 - Definitive additional proxy materials update shareholders ahead of upcoming votes.WMS
Proxy Filing1 Dec 2025 - Definitive proxy materials filed, detailing shareholder voting matters and engagement process.WMS
Proxy Filing1 Dec 2025 - Net sales up 1.8%, EBITDA margin 33.5%, Infiltrator surged, net income down 11.2%.WMS
Q1 202623 Nov 2025 - FY25 net sales up 1% to $2.90B, with margin pressure and cautious FY26 outlook.WMS
Q4 202518 Nov 2025